Interaction Between Sulindac and Warfarin: Different Results in Normal Subjects and in an Unusual Patient with a Potassium‐Losing Renal Tubular Defect
- 12 November 1979
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 19 (11) , 733-742
- https://doi.org/10.1002/j.1552-4604.1979.tb01644.x
Abstract
While sulindac failed to affect significantly warfarin-induced hypoprothrombinemia in normal male volunteers, it markedly prolonged prothrombin time in a patient with a renal tubular defect who had been anticoagulated with warfarin. This difference in individual response regarding a drug interaction illustrates the need to adjust information on drug interactions to the particular clinical circumstances and conditions under which drugs are coadministered.This publication has 8 references indexed in Scilit:
- The Kallikrein-Kinin System in Bartter's Syndrome and Its Response to Prostaglandin Synthetase InhibitionJournal of Clinical Investigation, 1978
- Indomethacin Disposition and Indomethacin‐Induced Platelet Dysfunction in Premature InfantsThe Journal of Clinical Pharmacology, 1978
- Prostaglandin Synthetase Inhibitors in Bartter's SyndromeJAMA, 1978
- The disposition of sulindacClinical Pharmacology & Therapeutics, 1977
- Bartter's syndrome: A disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesisThe American Journal of Medicine, 1976
- Failure of Indomethacin and Warfarin to Interact in Normal Human VolunteersThe Journal of Clinical Pharmacology, 1975
- Liquid Chromatographic Assay of Warfarin: Similarity of Warfarin Half-Lives in Human SubjectsScience, 1974
- The Clinical Application of the Hippuric Acid and the Prothrombin TestsAmerican Journal of Clinical Pathology, 1940